HER2 mediates clinical resistance to the KRASG12C inhibitor sotorasib, which is overcome by co-targeting SHP2
Titel:
HER2 mediates clinical resistance to the KRASG12C inhibitor sotorasib, which is overcome by co-targeting SHP2
Auteur:
Ho, Cassandra S.L. Tüns, Alicia I. Schildhaus, Hans-Ulrich Wiesweg, Marcel Grüner, Barbara M. Hegedus, Balazs Schuler, Martin Schramm, Alexander Oeck, Sebastian